Unit 2

A national pharmacovigilance program is a critical initiative aimed at ensuring the safety and efficacy of medicines throughout their lifecycle, from pre-market clinical trials to post-marketing surveillance. The primary goal of such a program is to monitor, assess, and mitigate the risks associated with the use of pharmaceutical products. Establishing a comprehensive national pharmacovigilance program…

Contract Research Organizations (CROs) are specialized service providers that offer comprehensive research and development (R&D) support to the pharmaceutical, biotechnology, and medical device industries. These organizations provide outsourced services to streamline the clinical trial process, from preclinical development through to post-marketing surveillance. CROs play a critical role in the development of new drugs and treatments…

Establishing and operating a Drug Safety Department in a pharmaceutical company is vital for ensuring the safety and efficacy of drugs throughout their lifecycle, from preclinical development to post-marketing surveillance. The primary goal of a Drug Safety Department, also known as Pharmacovigilance, is to identify, assess, and mitigate the risks associated with the use of…

Introduction to Pharmacovigilance Pharmacovigilance Programme in a Hospital: Pharmacovigilance (PV) is a critical component in ensuring the safety of medicinal products. It involves the collection, detection, assessment, understanding, and prevention of adverse drug reactions (ADRs) and other drug-related problems. The primary goal of pharmacovigilance is to ensure patient safety, minimize risks, and enhance the safe…

Basic drug information resources Basic drug information resources: Pharmacovigilance, the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem, is heavily reliant on information—accurate, timely, and evidence-based. The integrity of pharmacovigilance systems depends on the quality and accessibility of drug information resources. These resources can…

The WHO Drug Dictionary (WHO-DD) is an internationally recognized database of medicinal products and their related information, developed and maintained by the Uppsala Monitoring Centre (UMC), the World Health Organization’s Collaborating Centre for International Drug Monitoring. It is primarily used in pharmacovigilance, clinical trials, and drug safety monitoring for identifying and coding medications across various…

MedDRA and SMQs MedDRA and SMQs: MedDRA (Medical Dictionary for Regulatory Activities) is a globally standardized medical terminology developed by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). It is used in regulatory submissions, clinical trials, and post-marketing surveillance to describe adverse drug reactions (ADRs), medical conditions, and therapeutic…

In pharmacovigilance, drug dictionaries and coding systems play a crucial role in ensuring accurate and consistent documentation, reporting, and analysis of drug-related information, especially in the context of adverse drug reactions (ADRs). These standardized systems help in the collection, classification, and analysis of drug safety data, ensuring uniformity across regions and institutions. Coding systems facilitate…